Original Articles

The effectiveness of risperidone on PANSS score and IL-6 in confirmed COVID-19 schizophrenic patients

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 15 June 2024
Accepted: 10 July 2024
Published: 22 July 2024
904
Views
386
Downloads
17
HTML

Authors

The study aimed to determine the efficacy of risperidone on PANSS scores and Interleukin 6 (IL-6) levels in schizophrenia patients with confirmed COVID-19. The study type was analytical observational, with a prospective cohort design. The subjects included inpatient Schizophrenia patients with and without COVID-19, mild-moderate and asymptomatic COVID-19, and schizophrenic patients without COVID-19 who were hospitalized and met the inclusion and exclusion criteria, for a total of 22 subjects in each group. The Positive and Negative Syndrome Scale (PANSS) and Elisa Interleukin 6 (IL-6) serum were sampled consecutively for this study. In the positive covid-19 group, the Mean IL-6 Post was significantly lower than Pre (23.0 vs. 26.1, p<0.001), while in the control group, the Mean IL-6 Post (four weeks) was significantly lower than Pre (baseline), with 19.3 vs. 21.0 (p<0.001). Serum IL-6 levels appeared to be an effective prognostic biomarker in COVID-19 patients. The 35 pg/mL cut-off point could distinguish mild-moderate patients from more severe ones. We discovered that schizophrenia patients with verified positive COVID-19 received COVID-19 therapy in the form of a combination of antipsychotic and antivirals had IL-6 levels lower than 35 pg/mL, indicating the role of antipsychotic (risperidone) and antiviral in reducing IL-6 levels.

Downloads

Download data is not yet available.
Kementerian Kesehatan RI. Buku Pegangan Sosilaisasi Jaminan Kesehatan Nasional (JKN) dalam Sistem Jaminan Sosial Nasional [Internet]. Jakarta: Kementerian Kesehatan RI; 2014. 76 p. Available from: https://luk.staff.ugm.ac.id/atur/bpjs/BukuPeganganSosialisasiJKN-SJSN.pdf
Santoso B, Hendrartini J, Djoko Rianto BU, Trisnantoro L. System for Detection of National Healthcare Insurance Fraud Based on Computer Application. PHI 2018;4:46–56.
Palutturi S, Makkurade SR, Putri SE. Potential for Fraud of Health Service Claims to BPJS Health at Tenriawaru Public Hospital, Bone Regency, Indonesia. Internat J Innovat Creativity Change 2019;8:21.
Abu K. Potential of hospital fraud in the indonesia national health insurance era. a descriptive phenomenological research. Indian J Forensic Med Toxicol 2020;14:1132–6.
Maidin A, Palutturi S. The study of implementation of National Health Insurance Cross Province (South Sulawesi, South East Sulawesi And, West Sulawesi), 2014. Jurnal Kebijakan Kesehatan Indonesia 2016;5:96–100.
Achmad T, Ghozali I, Pamungkas ID. Hexagon fraud: detection of fraudulent financial reporting in state-owned enterprises Indonesia. Economies 2022;10:13.
Vousinas GL. Advancing theory of fraud: the S.C.O.R.E. model. J Financial Crime 2019;26:372–81.
Sadikin H, Adisasmito W. Analisis Pengaruh Dimensi Fraud Triangle Dalam Kebijakan Pencegahan Fraud Terhadap Program Jaminan Kesehatan Nasional di RSUP Nasional Cipto Mangunkusumo. Jurnal Ekonomi Kesehatan Indonesia 2016;1:28–34.
Agus Bandiyono. Fraud detection: religion in the workplace big data analytics. Jurnal Akuntans. 2023;27:380–400.
Firmansyah Y, Haryanto I, Ernawati. Fraud issues in the national health insurance (causes, legal impacts, dispute settlement and preventive measures). Jurnal Multidisiplin Madani (MUDIMA) 2022;2:1663–80.
Fund IM. Financial system abuse, financial crime and money laundering - background paper. Policy Papers 2001;2001:039.
Vian T. Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches. Glob Health Action 2020;13:1694744.
Sun X, Chen Y. Why do people with similar levels of internal control differ in their likelihood to commit fraud? Analysis of the moderating effect of perceived opportunity to commit fraud. Front Psychol 2022;13:999469.
Abdullahi R, Mansor N. Fraud triangle theory and fraud diamond theory. Understanding the convergent and divergent for future research. IJARAFMS 2015;5:38-45.
Fernandhytia F, Muslichah M. The effect of internal control, individual morality and ethical value on accounting fraud tendency. Media Ekonomi dan Manajemen 2020;35:112–27.
Yulianti Y, Zarkasyi MW, Suharman H, Soemantri R. Effects of professional commitment, commitment to ethics, internal locus of control and emotional intelligence on the ability to detect fraud through reduced audit quality behaviors. J Islamic Account Business Res 2024;15:385-401.
Anderson C, Sharps DL, Soto CJ, John OP. People with disagreeable personalities (selfish, combative, and manipulative) do not have an advantage in pursuing power at work. Proceedings Nat Acad Sci 2020;117:22780–6.
Milyavsky M, Kruglanski AW, Chernikova M, Schori-Eyal N. Evidence for arrogance: On the relative importance of expertise, outcome, and manner. PLoS One 2017;12:e0180420.
Villegas-Ortega J, Bellido-Boza L, Mauricio D. Fourteen years of manifestations and factors of health insurance fraud, 2006–2020: a scoping review. Health Justice 2021;9:26.
Kartini K. Developing fraud prevention model in regional public hospital in West Sulawesi Province. Internat J Law Manag 2018;60:210–20.

How to Cite



The effectiveness of risperidone on PANSS score and IL-6 in confirmed COVID-19 schizophrenic patients. (2024). Healthcare in Low-Resource Settings, 13(1). https://doi.org/10.4081/hls.2024.12723